Have a personal or library account? Click to login
Type I interferon therapies of multiple sclerosis and hepatitis C virus infection Cover

Type I interferon therapies of multiple sclerosis and hepatitis C virus infection

Postępy Higieny i Medycyny Doświadczalnej
Volume 75 (2021): Issue 1 (January 2021)
By: Izabella Jasyk and  Jakub Siednienko  
Open Access
|Oct 2021

Authors

Izabella Jasyk

Izabella.jasyk@port.lukasiewicz.gov.pl

Laboratory of Microbiome Immunobiology, Institute of Immunology and Experimental Therapy, Polish Academy of Science, Wroclaw, Poland
Bioengineering Research Group, Łukasiewicz Research Network-PORT Polish Center for Technology Development, Wroclaw, Poland

Jakub Siednienko

Bioengineering Research Group, Łukasiewicz Research Network-PORT Polish Center for Technology Development, Wroclaw, Poland
DOI: https://doi.org/10.2478/ahem-2021-0001 | Journal eISSN: 1732-2693
Journal RSS Feed
Language: English
Page range: 537 - 547
Submitted on: Nov 16, 2020
|
Accepted on: Apr 23, 2021
|
Published on: Oct 21, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
interferon type I,
multiple sclerosis,
hepatitis C virus,
MAP kinases,
NF-κB,
STAT
Related subjects:
Life sciences,
Molecular biology,
Microbiology and virology,
Medicine,
Basic medical science,
Immunology

© 2021 Izabella Jasyk, Jakub Siednienko, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 75 (2021): Issue 1 (January 2021)Next article